Evidence map›Paper›PMID 19356948›Full record

ReviewTrends in endocrinology and metabolism: TEM2009

Mitochondrial protein phosphorylation: instigator or target of lipotoxicity?

Wolfgang F Graier, Roland Malli, Gerhard M Kostner

Open access · greenAbstract readReview
In one paragraph

Review in Trends in endocrinology and metabolism: TEM, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. The effect of dietary habits on oocyte/sperm quality.Journal of the Turkish German Gynecological Association · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Mitochondria and ageing: role in heart, skeletal muscle and adipose tissue.Journal of cachexia, sarcopenia and muscle · 2017
    Review
  7. Review
  8. Article
  9. Review
  10. Endothelial mitochondria--less respiration, more integration.Pflugers Archiv : European journal of physiology · 2012
    Review
  11. Article
  12. Article
  13. Article
  14. Glucolipotoxicity of the pancreatic beta cell.Biochimica et biophysica acta · 2010
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Wolfgang F GraierInstitute of Molecular Biology and Biochemistry, Center of Molecular Medicine, Medical University Graz, Graz, Austria. wolfgang.graier@medunigraz.at
Roland Malli
Gerhard M Kostner
Medical University of Graz · AT

Funding

Austrian Science Fund FWF F 3010Austrian Science Fund FWF P 20181
6 · The paper itself

Abstract

Lipotoxicity occurs as a consequence of chronic exposure of non-adipose tissue and cells to elevated concentrations of fatty acids, triglycerides and/or cholesterol. The contribution of mitochondria to lipotoxic cell dysfunction, damage and death is associated with elevated production of reactive oxygen species and initiation of apoptosis. Although there is a broad consensus on the involvement of these phenomena with lipotoxicity, the molecular mechanisms that initiate, mediate and trigger mitochondrial dysfunction in response to substrate overload remain unclear. Here, we focus on protein phosphorylation as an important phenomenon in lipotoxicity that harms mitochondria-related signal transduction and integration in cellular metabolism. Moreover, the degradation of mitochondria by mitophagy is discussed as an important landmark that leads to cellular apoptosis in lipotoxicity.

Indexed as

AnimalsApoptosisDietary FatsHumansMitochondriaMitochondrial ProteinsModels, BiologicalPhosphorylationSignal TransductionDietary FatsMitochondrial Proteins

Identifiers

PMID19356948
PMCPMC4861235
OpenAlexW2060129257

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.